Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical studies with transdermal nitroglycerin.

M Hollenberg, M Go

    American Heart Journal
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Nitro-Dur improves exercise performance and hemodynamics in men with angina, but its effects on blood pressure diminish over time. Cardiac responsiveness remains preserved with prolonged use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cost-effectiveness and safety of the molecular targeted drugs afatinib, gefitinib and erlotinib as first-line treatments for patients with advanced EGFR mutation-positive non-small-cell lung cancer.

    Molecular and clinical oncology·2018
    Same author

    Infection-related complications during treatment for childhood acute lymphoblastic leukemia.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer.

    Die Pharmazie·2016
    Same author

    The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
    Same author

    Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma.

    Leukemia·2010
    Same author

    Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis.

    Alimentary pharmacology & therapeutics·2008
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Stable angina pectoris affects many individuals, necessitating effective therapeutic strategies.
    • Nitroglycerin formulations are commonly used for managing angina symptoms.

    Purpose of the Study:

    • To evaluate the short- and long-term effects of Nitro-Dur on exercise performance and hemodynamics in men with stable angina.
    • To compare the efficacy of Nitro-Dur with sublingual nitroglycerin.

    Main Methods:

    • 15 men with stable angina and positive treadmill exercise tests participated.
    • A treadmill exercise score (TES) quantified the "ischemic" ST segment response.
    • Hemodynamic parameters including blood pressure and heart rate were monitored.

    Main Results:

    Related Experiment Videos

  • Nitro-Dur significantly improved TES and the time to 1 mm ST segment depression (p < 0.0001).
  • Nitro-Dur decreased resting systolic blood pressure and increased resting heart rate.
  • Long-term Nitro-Dur use showed attenuated effects on blood pressure and heart rate, but preserved cardiac responsiveness.

    • Conclusions:

    • Nitro-Dur demonstrates short-term efficacy in improving exercise capacity and hemodynamic parameters in angina patients.
    • While tolerance may develop to hemodynamic effects, cardiac responsiveness is maintained with prolonged Nitro-Dur use.
    • Findings have implications for designing individualized patient therapy regimens.